This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Intrexon Corporation, University of Pittsburgh. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 121 
1 out of 1,963 
Years Active: 2017
Title: J Mark Braughler: Innovator in Cancer Treatment
Introduction
J Mark Braughler is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of therapeutics, particularly in the treatment of cancer. His innovative work focuses on engineered dendritic cells, which play a crucial role in advancing cancer therapies.
Latest Patents
J Mark Braughler holds a patent for "Engineered dendritic cells and uses for the treatment of cancer." This invention provides methods for generating in vitro engineered dendritic cells that conditionally express interleukin-12 (IL-12) under the control of a gene expression modulation system. The invention aims to enhance therapeutic applications in animals, including humans.
Career Highlights
Throughout his career, J Mark Braughler has worked with prominent organizations such as Intrexon Corporation and the University of Pittsburgh. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer treatment.
Collaborations
Some of his notable coworkers include Walter J Storkus and Prasanna Kumar. Their collaborative efforts have contributed to the advancement of research in the field of cancer therapeutics.
Conclusion
J Mark Braughler's work in engineered dendritic cells represents a significant advancement in cancer treatment. His innovative approaches and collaborations continue to influence the field of therapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile